HCT
Director Trades
| Date | Director | Value |
|---|
Company News
Holista CollTech confirms Path-Away ingredient can kill 99.9% of COVID-19 virus within 2mins
Natural wellness company Holista CollTech (ASX: HCT) has announced independent tests of Path-Away anti-pathogenic aerosol solution have shown the ingredient can kill 99.9% of the virus that causes COVID-19 within two minutes on a hard surface. United States-based accredited facility Microbac Laboratories Inc conducted the tests on the plant-based, alcohol-free product as a follow-up from […]
Holista CollTech reports Natshield hand sanitiser active ingredient to be 99.99% effective against feline coronavirus
Testing of the plant-based component in Natshield hand sanitisers developed by natural wellness company Holista CollTech (ASX: HCT) has confirmed it to be more than 99.99% effective against feline coronavirus, a surrogate of the COVID-19 novel coronavirus. According to Holista, results from the UK tests show the active ingredient known as Path-Away has an efficacy of 4.17Log […]
Skin Elements and Holista CollTech set to market ‘all-natural’ hand sanitiser in Australia
Natural wellness company Holista CollTech (ASX: HCT) and skincare specialist Skin Elements (ASX: SKN) released a joint statement this morning, announcing a binding deal to launch an alcohol-free hand sanitiser combining Skin Elements’ skin-sensitive anti-microbial formula with Holista’s Path-Away active ingredient. The initial order for the active ingredient was said to be a minimum of $600,000 in […]
Holista CollTech uses COVID-19 pandemic as platform to launch NatShield sanitiser in US
As the global COVID-19 pandemic worsens, Holista CollTech (ASX: HCT) is about to launch its NatShield sanitiser in the United States after appointing Health Therapies as the exclusive distributor for the country. The deal gives Health Therapies exclusive rights to sell the sanitiser into the US market for three years with the company also committing […]
Holista Holtech announces $1.4 million in 80Less sugar formulation sales
Natural wellness company Holista CollTech (ASX: HCT) has gained market traction for its 80Less product by signing a five-year supply agreement with Rex Industry Berhad. The deal will see Holista’s proprietary sugar formulation be used in a range of low-sugar beverage drinks by the Malaysia Bursa-listed drinks manufacturer with several products to be developed for […]
Holista CollTech joins forces with GICC to develop nasal sanitising balm
Biotech company Holista CollTech (ASX: HCT) is set to join the resistance against the coronavirus pandemic after announcing a deal with Global Infection Control Consultants (GICC) to co-develop and produce the world’s first nasal sanitising balm in Malaysia. The news means Holista will exclusively represent GICC’s technology in the Asia Pacific region with the exclusion of […]
Holista receives Australian and Asian orders for NatShield sanitiser to combat coronavirus
Perth-based biotech company Holista CollTech (ASX: HCT) has received orders for an additional 90,000 NatShield sanitisers to parts of Australia and Asia, just days after the first delivery was sold out amid rising concerns of the spread of the novel coronavirus 2019-nCoV. The company confirmed it had received an order last week for 60,000 units […]
Holista secures first order as part of multimillion dollar sales deal for healthy low-GI noodles
Biotech company and food manufacturer Holista CollTech’s (ASX: HCT) has struck a chord with its consumer market base by signing its first commercial order for its patented “low-GI noodles”, an all natural and minimally processed variety of noodles that are particularly low in sugar. Holista announced a deal with Ontario-based Wing’s Food Products, the leading […]